Clinical trial
Safety and Efficacy of SH T00660AA in Treatment of Endometriosis
NCT00225186 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00225186 |
|---|---|
| Title | Safety and Efficacy of SH T00660AA in Treatment of Endometriosis |
| Official title | A Multi-center, Open, One-arm Study to Investigate the Safety and Efficacy of Daily Oral Administration of T00660AA for the Treatment of Endometriosis Over 52 Weeks (Follow-up to Study 307041) |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Endometriosis |
| Intervention type | Drug |
| Interventions | Visanne (SH T00660AA, BAY86-5258) |
| Enrollment | 168 |
| Start date | Jul 1, 2004 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Sep 23, 2005 |
| Last update posted | Jan 9, 2014 |
| Countries | Germany, Italy, Ukraine |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: